Reirradiation of locally recurrent prostate cancer after primary radiotherapy

Reirradiation of locally recurrent prostate cancer after primary radiotherapy Biochemical recurrence can occur after definitive treatment with external beam radiation therapy (EBRT) or brachytherapy (BRT) for localized prostate cancer. Prior to considering reirradiation for recurrent prostate cancer, appropriate patient selection is important in ensuring that patients are at a high likelihood for a local only recurrence. For appropriately selected patients, careful reirradiation using mostly brachytherapy techniques can provide durable long-term control with acceptable morbidity. Most of the published experience with reirradiation has been using low-dose rate (LDR) BRT, but early results using high-dose rate (HDR) BRT have also been promising. Generally, the use of EBRT as well as stereotactic body radiation therapy (SBRT) is still uncommon in a reirradiation setting, and further study will need to be performed to characterize its biochemical outcomes and toxicities. The radiation therapy oncology group (RTOG) 0526 is a recently closed phase II prospective trial that is investigating the role of reirradiation using LDR brachytherapy. Results from this study will help physicians better understand the long-term toxicities and biochemical outcomes of reirradiation using LDR BRT. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Radiation Oncology Springer Journals

Reirradiation of locally recurrent prostate cancer after primary radiotherapy

Loading next page...
 
/lp/springer-journals/reirradiation-of-locally-recurrent-prostate-cancer-after-primary-fuxF5ijPoY
Publisher
Springer Journals
Copyright
Copyright © 2015 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Imaging / Radiology; Cancer Research; Surgical Oncology; Surgery; Radiotherapy
ISSN
1948-7894
eISSN
1948-7908
DOI
10.1007/s13566-015-0191-x
Publisher site
See Article on Publisher Site

Abstract

Biochemical recurrence can occur after definitive treatment with external beam radiation therapy (EBRT) or brachytherapy (BRT) for localized prostate cancer. Prior to considering reirradiation for recurrent prostate cancer, appropriate patient selection is important in ensuring that patients are at a high likelihood for a local only recurrence. For appropriately selected patients, careful reirradiation using mostly brachytherapy techniques can provide durable long-term control with acceptable morbidity. Most of the published experience with reirradiation has been using low-dose rate (LDR) BRT, but early results using high-dose rate (HDR) BRT have also been promising. Generally, the use of EBRT as well as stereotactic body radiation therapy (SBRT) is still uncommon in a reirradiation setting, and further study will need to be performed to characterize its biochemical outcomes and toxicities. The radiation therapy oncology group (RTOG) 0526 is a recently closed phase II prospective trial that is investigating the role of reirradiation using LDR brachytherapy. Results from this study will help physicians better understand the long-term toxicities and biochemical outcomes of reirradiation using LDR BRT.

Journal

Journal of Radiation OncologySpringer Journals

Published: Apr 30, 2015

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create folders to
organize your research

Export folders, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off